Global Markets
Genmab (GMAB DC) sees FY profit between USD 3.81-4.11bln, sees FY EBIT between USD 0.9-1.4bln; sees FY operating expenses between USD 2.71-2.91bln
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
